AcrySof Toric Clinical Results
Information source: Alcon Research
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cataracts; Astigmatism
Intervention: T3 (Device); T4 (Device); T5 (Device)
Phase: Phase 4
Status: Completed
Sponsored by: Alcon Research
Summary
This study is an evaluation of visual outcomes of subjects implanted with the AcrySof Toric
Intraocular Lenses (IOLs) Models SN60T3, SN60T4, and SN60T5.
Clinical Details
Official title: Clinical Results With the AcrySof Toric Intraocular Lens (IOL)
Study design: Observational Model: Case-Only, Time Perspective: Prospective
Primary outcome: Visual Acuity
Secondary outcome: Postoperative refractive cylinder
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Diagnosed with cataracts; has astigmatism falling in range of AcrySof Toric lens as
assessed by the AcrySof Toric calculator
Exclusion Criteria:
- Ocular comorbidities affecting visual outcome data,
- Prior refractive surgery,
- Irregular astigmatism
Locations and Contacts
Alcon Call Center for Trial Locations, Fort Worth, Texas 76134, United States
Additional Information
Starting date: August 2007
Last updated: September 27, 2012
|
